Macular Retinoblastoma: Evaluation of Tumor Control, Local Complications, and Visual Outcomes for Eyes Treated with Chemotherapy and Repetitive Foveal Laser Ablation

Ophthalmology

Volumn 114, Issue 1, 2007, Pages 162-169

  Schefler, Amy C ^a   Cicciarelli, Nicole ^a   Feuer, William ^a   Toledano, Stuart ^b   Murray, Timothy G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOSPORIN; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CATARACT; CHILD; CLINICAL ARTICLE; DIODE LASER; DRUG DOSE REDUCTION; ENUCLEATION; EXTERNAL BEAM RADIOTHERAPY; EYE SYNECHIA; FEMALE; HUMAN; INFANT; IRIS ATROPHY; LASER SURGERY; LOW LEVEL LASER THERAPY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PUPIL DISEASE; RECURRENT DISEASE; RETINA FOVEA; RETINOBLASTOMA; STRABISMUS; TREATMENT DURATION; VISUAL FIELD;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; ETOPOSIDE; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INTRAOPERATIVE COMPLICATIONS; LASER SURGERY; MALE; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINCRISTINE; VISUAL ACUITY;

EID: 33845811091     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.06.042     Document Type: Article

References (35)

1. Abramson D.H., and Frank C.M. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 105 (1998) 573-579 discussion 579-80
2. Moll A.C., Imhof S.M., Schouten-Van Meeteren A.Y., et al. Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997. Is there an age effect on radiation-related risk?. Ophthalmology 108 (2001) 1109-1114
3. Li F.P., Abramson D.H., Tarone R.E., et al. Hereditary retinoblastoma, lipoma, and second primary cancers. J Natl Cancer Inst 89 (1997) 83-84
4. Abramson D.H., Melson M.R., Dunkel I.J., and Frank C.M. Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma. Ophthalmology 108 (2001) 1868-1876
5. Wong F.L., Boice Jr. J.D., Abramson D.H., et al. Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA 278 (1997) 1262-1267
6. Murray T.G., Cicciarelli N., McCabe C.M., et al. In vitro efficacy of carboplatin and hyperthermia in a murine retinoblastoma cell line. Invest Ophthalmol Vis Sci 38 (1997) 2516-2522
7. Murray T.G., Cicciarelli N., O'Brien J.M., et al. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma. Arch Ophthalmol 115 (1997) 1286-1290
8. Gallie B.L., Budning A., DeBoer G., et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 114 (1996) 1321-1328
9. Kingston J.E., Hungerford J.L., Madreperla S.A., and Plowman P.N. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 114 (1996) 1339-1343
10. Murphree A.L., Villablanca J.G., Deegan III W.F., et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 114 (1996) 1348-1356
11. Shields C.L., De Potter P., Himelstein B.P., et al. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114 (1996) 1330-1338
12. Greenwald M.J., and Strauss L.C. Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy. Ophthalmology 103 (1996) 1989-1997
13. Chan H.S., DeBoer G., Thiessen J.J., et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 2 (1996) 1499-1508
14. Shields C.L., Shields J.A., Needle M., et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 104 (1997) 2101-2111
15. Gunduz K., Shields C.L., Shields J.A., et al. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma. Arch Ophthalmol 116 (1998) 1613-1617
16. Levy C., Doz F., Quintana E., et al. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results. Br J Ophthalmol 82 (1998) 1154-1158
17. Friedman D.L., Himelstein B., Shields C.L., et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 18 (2000) 12-17
18. Beck M.N., Balmer A., Dessing C., et al. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. J Clin Oncol 18 (2000) 2881-2887
19. Wilson M.W., Rodriguez-Galindo C., Haik B.G., et al. Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma. Ophthalmology 108 (2001) 2106-2114 discussion 2114-5
20. Shields C.L., Honavar S.G., Meadows A.T., et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 133 (2002) 657-664
21. Shields C.L., Honavar S.G., Shields J.A., et al. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 120 (2002) 460-464
22. Shields C.L., Honavar S.G., Meadows A.T., et al. Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 120 (2002) 1653-1658
23. Brichard B., De Bruycker J.J., De Potter P., et al. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Med Pediatr Oncol 38 (2002) 411-415
24. Gombos D.S., Kelly A., Coen P.G., et al. Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age. Br J Ophthalmol 86 (2002) 80-83
25. Rodriguez-Galindo C., Wilson M.W., Haik B.G., et al. Treatment of intraocular retinoblastoma with vincristine and carboplatin. J Clin Oncol 21 (2003) 2019-2025
26. Shields C.L., Mashayekhi A., Cater J., et al. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors. Arch Ophthalmol 123 (2005) 765-773
27. Balasubramanya R., Pushker N., Bajaj M.S., et al. Visual outcome in macular retinoblastoma treated with primary chemotherapy. Ophthalmologica 217 (2003) 417-421
28. Desjardins L., Chefchaouni M.C., Lumbroso L., et al. Functional results after treatment of retinoblastoma. J AAPOS 6 (2002) 108-111
29. Benz M.S., Scott I.U., Murray T.G., et al. Complications of systemic chemotherapy as treatment of retinoblastoma. Arch Ophthalmol 118 (2000) 577-578
30. Shields C.L., Meadows A.T., Leahey A.M., and Shields J.A. Continuing challenges in the management of retinoblastoma with chemotherapy. Retina 24 (2004) 849-862
31. Brichard B., De Bruycker J.J., De Potter P., et al. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Med Pediatr Oncol 38 (2002) 411-415
32. Abramson D.H., and Gombos D.S. The topography of bilateral retinoblastoma lesions. Retina 16 (1996) 232-239
33. Shields C.L., Mashayekhi A., Cater J., et al. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Trans Am Ophthalmol Soc 102 (2004) 35-44 discussion 44-5
34. Shields C.L., Santos M.C., Diniz W., et al. Thermotherapy for retinoblastoma. Arch Ophthalmol 117 (1999) 885-893
35. Abramson D.H., and Schefler A.C. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma. Technique and predictors of success. Ophthalmology 111 (2004) 984-991